GO:0036344 platelet morphogenesis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036344 platelet morphogenesis describes the generation and organization of platelets, the non-nucleated disk-shaped blood cells that mediate coagulation.
• Platelet morphogenesis occurs primarily through megakaryocyte cytoplasmic fragmentation, but the lung has been identified as a major site of platelet biogenesis and a reservoir for haematopoietic progenitors.
• Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells have been described, expanding the classical megakaryocyte-centric model.
• Platelet formation and activation are influenced by neuronal guidance proteins, linking haemostasis to neurovascular guidance cues.
• Human induced pluripotent stem cells can be differentiated into megakaryocytes and functional platelets, providing a scalable model for studying platelet morphogenesis.
• Platelet-derived factors such as CXCL4/platelet factor 4 and LPA16:0 influence adult hippocampal neurogenesis and stress resilience, showing that platelet morphogenesis has functions beyond haemostasis.
Description
Platelet morphogenesis (GO:0036344) is the biological process that generates and organizes platelets, the non-nucleated disk-shaped cells found in the blood of all mammals that are mainly involved in blood coagulation. Platelets are essential for haemostasis, but they also participate in inflammation, tissue repair, and neurogenesis, making the study of their formation relevant across multiple biomedical disciplines. The classical view holds that platelets arise from the cytoplasm of megakaryocytes in the bone marrow, but recent work has shown that the lung is a major site of platelet biogenesis and a reservoir for haematopoietic progenitors. In addition, alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells have been identified, indicating that platelet morphogenesis is more heterogeneous than previously appreciated. Understanding the molecular and cellular steps of platelet morphogenesis is therefore important for basic haematology, regenerative medicine, and the development of platelet-based therapies.
platelet morphogenesis At A Glance
| GO ID | GO:0036344 |
|---|---|
| GO term | platelet morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Generation and organization of platelets from megakaryocytes for blood coagulation |
| Primary site | Bone marrow and lung |
| Key cell type | Megakaryocyte and platelet |
| Related process | Haematopoiesis and platelet activation |
| Model systems | Induced pluripotent stem cell-derived megakaryocytes and platelets |
What Is GO:0036344?
According to the Gene Ontology, platelet morphogenesis (GO:0036344) is the generation and organization of a platelet, a non-nucleated disk-shaped cell formed by extrusion from megakaryocytes, found in the blood of all mammals, and mainly involved in blood coagulation. In other words, it covers the cellular events that build a platelet from its megakaryocyte precursor and organize its structural components into a functional circulating cell.
Why Is platelet morphogenesis Important in Cell Biology?
Platelet morphogenesis is important because platelets are indispensable for haemostasis, and defects in their production or organization lead to bleeding or thrombotic disorders. Beyond coagulation, platelets influence neurogenesis and cognitive function through secreted factors such as CXCL4/platelet factor 4 and LPA16:0, linking platelet morphogenesis to brain health and aging. The discovery that the lung is a major site of platelet biogenesis and a reservoir for haematopoietic progenitors has reshaped the field and opened new avenues for studying platelet production outside the bone marrow. Alternative differentiation pathways from nonhierarchically related hematopoietic stem cells further highlight the complexity of platelet morphogenesis and its relevance to regenerative medicine. Because platelets can be generated from induced pluripotent stem cells, platelet morphogenesis is also a tractable target for cell-based therapies and disease modeling.
• Platelets are essential for blood coagulation and prevention of haemorrhage.
• The lung is a major site of platelet biogenesis and a reservoir for haematopoietic progenitors, expanding the anatomical scope of platelet morphogenesis.
• Alternative platelet differentiation pathways from nonhierarchically related hematopoietic stem cells reveal heterogeneity in platelet production.
• Platelet formation and activation are influenced by neuronal guidance proteins, connecting haemostasis with neurovascular biology.
• Platelet-derived CXCL4/platelet factor 4 rejuvenates hippocampal neurogenesis and restores cognitive function in aged mice.
• Platelet-derived LPA16:0 inhibits stress resilience and adult hippocampal neurogenesis in anxiety models.
• Induced pluripotent stem cells can produce megakaryocytes and platelets, enabling scalable study of platelet morphogenesis.
• Defects in platelet morphogenesis contribute to thrombocytopenia and platelet function disorders.
• Platelet morphogenesis is a target for regenerative medicine and cell therapy development.
• Understanding platelet morphogenesis informs the design of platelet-inspired therapeutics and drug delivery systems.
What Happens During platelet morphogenesis?
Megakaryocyte differentiation and maturation
In simple terms: Stem cells in the bone marrow become large precursor cells called megakaryocytes.
Platelet morphogenesis begins with the differentiation of haematopoietic stem cells into megakaryocytes, the large polyploid cells that will produce platelets. Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells have been described, indicating that multiple routes can lead to megakaryocyte-like precursors. During maturation, megakaryocytes develop an extensive internal membrane system and accumulate platelet-specific granules and cytoskeletal proteins. This step is regulated by lineage-specific transcription factors and cytokines, and can be recapitulated in vitro using induced pluripotent stem cells.
Proplatelet formation and cytoplasmic fragmentation
In simple terms: The megakaryocyte extends long branches that break off into individual platelets.
Mature megakaryocytes extend long cytoplasmic protrusions called proplatelets, which fragment to release platelets into the circulation. This process requires coordinated reorganization of the microtubule and actin cytoskeleton, and is influenced by neuronal guidance proteins that modulate platelet formation and activation. Proplatelet formation is a hallmark of platelet morphogenesis and can be studied in vitro using megakaryocytes derived from induced pluripotent stem cells.
Lung as a site of platelet biogenesis
In simple terms: The lungs also make platelets, not just the bone marrow.
The lung has been identified as a major site of platelet biogenesis and a reservoir for haematopoietic progenitors, with megakaryocytes residing in the pulmonary circulation and releasing platelets directly into the bloodstream. This discovery expanded the classical view of platelet morphogenesis beyond the bone marrow and highlighted the lung as a key organ for platelet production. The pulmonary niche provides unique mechanical and biochemical cues that support platelet release.
Platelet organization and structural maturation
In simple terms: Newly made platelets organize their internal parts to become functional.
After release, platelets undergo organization of their internal structures, including the marginal microtubule coil, alpha-granules, dense granules, and the open canalicular system, to become functional disk-shaped cells. This structural maturation is essential for platelet activation and aggregation during coagulation. Platelet morphogenesis thus encompasses not only the generation of platelets but also their organization into a competent haemostatic cell.
Key Genes Involved in GO:0036344 platelet morphogenesis
The following genes and proteins are involved in platelet morphogenesis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PF4 (CXCL4) | Platelet-derived chemokine that influences neurogenesis and cognition | Target for studying platelet-brain interactions |
| LPA16:0 | Platelet-derived lipid mediator that inhibits stress resilience and neurogenesis | Model for anxiety and hippocampal neurogenesis research |
| HSC markers | Markers of hematopoietic stem cells that initiate alternative platelet differentiation pathways | Used to trace platelet lineage origins |
| Megakaryocyte lineage genes | Drive megakaryocyte differentiation and maturation | Essential for in vitro platelet production |
| Neuronal guidance proteins | Influence platelet formation and activation | Link haemostasis with neurovascular guidance |
| iPSC reprogramming factors | Enable generation of megakaryocytes and platelets from induced pluripotent stem cells | Platform for disease modeling and cell therapy |
| Cytoskeletal regulators | Control proplatelet formation and platelet release | Targets for modulating platelet production |
| Granule cargo proteins | Package platelet granules during morphogenesis | Markers of platelet maturation |
| Lung niche factors | Support platelet biogenesis in the pulmonary circulation | Study of extramedullary platelet production |
| Haematopoietic progenitors | Reservoir for platelet-producing cells in the lung | Source for platelet regeneration studies |
| Platelet concentrate-derived EV markers | Mediate neurogenesis via extracellular vesicles | Therapeutic potential for brain repair |
| Thrombopoietin signaling components | Regulate megakaryocyte growth and platelet production | Target for thrombocytopenia treatment |
| Transcription factors for megakaryopoiesis | Drive lineage commitment | Used to reprogram stem cells toward platelets |
| Adhesion molecules | Facilitate platelet release and organization | Targets for antiplatelet strategies |
| Membrane remodeling proteins | Shape proplatelets and platelets | Studied in platelet morphogenesis assays |
| Signaling kinases | Regulate cytoskeletal dynamics during platelet formation | Potential drug targets |
| Extracellular matrix components | Provide niche support for megakaryocytes | Model lung and bone marrow niches |
| Exerkine-related factors | Platelet-derived factors that affect aging and cognition | Exercise mimetic research |
How Is platelet morphogenesis Regulated?
Platelet morphogenesis is regulated by a combination of intrinsic transcriptional programs and extrinsic cues from the bone marrow and lung microenvironments. Neuronal guidance proteins have been shown to influence platelet formation and activation, adding a layer of regulation that connects haemostasis with neurovascular signaling. Alternative differentiation pathways initiated by nonhierarchically related hematopoietic stem cells suggest that platelet production is not a single linear process but is subject to multiple regulatory inputs. Platelet-derived factors such as CXCL4/platelet factor 4 and LPA16:0 can also feed back on neurogenesis and stress responses, indicating systemic regulation beyond the vasculature.
platelet morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PF4 (CXCL4) | Cognitive aging and neurogenesis | Knockout mouse and hippocampal neurogenesis assays |
| LPA16:0 | Anxiety and stress resilience | Overexpression or inhibition in mouse models |
| Megakaryocyte lineage genes | Thrombocytopenia | iPSC-derived megakaryocytes with CRISPR knockout |
| Neuronal guidance proteins | Platelet function disorders and neurovascular disease | Point-mutation knock-in in megakaryocyte cell lines |
| Platelet-derived EVs | Neurodegeneration and brain repair | Extracellular vesicle treatment in animal models |
Thrombocytopenia and platelet function disorders
Defects in platelet morphogenesis can lead to thrombocytopenia, a condition characterized by low platelet counts and increased bleeding risk. Impaired megakaryocyte maturation or proplatelet formation results in reduced platelet production, and understanding these steps is essential for developing treatments. The lung as a site of platelet biogenesis may also contribute to platelet recovery after injury or disease.
Neurodegeneration and cognitive aging
Platelet-derived CXCL4/platelet factor 4 has been shown to rejuvenate hippocampal neurogenesis and restore cognitive function in aged mice, linking platelet morphogenesis to brain aging. Conversely, platelet-derived LPA16:0 inhibits stress resilience and adult hippocampal neurogenesis in anxiety models, suggesting that platelet factors can have detrimental effects on brain function. Platelet concentrate-derived extracellular vesicles promote adult hippocampal neurogenesis, highlighting the therapeutic potential of platelet products for neurodegenerative conditions.
Cancer and metastasis
Platelets are known to interact with cancer cells and facilitate metastasis, although the specific role of platelet morphogenesis in cancer progression is an active area of research. Neuronal guidance proteins that influence platelet formation and activation may also play roles in tumor angiogenesis and metastasis. Further studies are needed to clarify how platelet morphogenesis contributes to cancer biology.
From platelet morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate megakaryocyte differentiation? | CRISPR knockout in iPSC-derived megakaryocytes |
| Does a point mutation in gene Y affect proplatelet formation? | Point-mutation knock-in in hematopoietic stem cells |
| Can gene Z overexpression enhance platelet production? | Overexpression in megakaryocyte cell lines |
| Where is protein W localized during platelet morphogenesis? | Tagged knock-in with fluorescent reporter |
| Does lung-specific gene V control platelet biogenesis? | Conditional knockout in mouse lung |
| Can CRISPR library screening identify novel platelet regulators? | Pooled CRISPR screen in megakaryocyte differentiation assays |
How to Study the platelet morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| iPSC differentiation | Generation of megakaryocytes and platelets | Disease modeling and drug screening |
| Live-cell imaging | Proplatelet formation and platelet release | Cytoskeletal dynamics studies |
| Flow cytometry | Platelet count and surface markers | Phenotyping of platelet disorders |
| RNA sequencing | Transcriptional profiles of megakaryocytes | Identification of lineage regulators |
| Proteomics | Protein composition of platelets | Discovery of novel platelet proteins |
| CRISPR screening | Gene function in platelet morphogenesis | High-throughput discovery of regulators |
| Electron microscopy | Ultrastructure of platelets | Structural organization studies |
| Platelet aggregation assays | Functional capacity of platelets | Haemostasis research |
In vitro megakaryocyte and platelet differentiation
Induced pluripotent stem cells can be differentiated into megakaryocytes and functional platelets, providing a scalable system to study platelet morphogenesis. This method allows genetic manipulation and high-throughput screening of candidate genes.
Imaging of proplatelet formation
Live-cell imaging and electron microscopy are used to visualize proplatelet formation and platelet release from megakaryocytes. These techniques reveal cytoskeletal dynamics and structural organization during platelet morphogenesis.
Flow cytometry and platelet function assays
Flow cytometry can quantify platelet production and surface marker expression, while aggregation and activation assays assess platelet function. These methods are essential for linking morphogenesis to haemostatic competence.
Transcriptomics and proteomics
RNA sequencing and proteomics of megakaryocytes and platelets can identify genes and proteins involved in platelet morphogenesis. Comparative analyses of bone marrow and lung megakaryocytes have revealed distinct molecular signatures.
How CRISPR Can Be Used to Study GO:0036344 platelet morphogenesis
Knockout
CRISPR knockout of candidate genes in iPSC-derived megakaryocytes can determine whether a gene is required for platelet morphogenesis. For example, knocking out megakaryocyte lineage genes impairs platelet production and can model thrombocytopenia.
Point Mutation
Point-mutation knock-in can replicate patient-specific variants in genes involved in platelet morphogenesis, allowing functional assessment of missense mutations. This approach is useful for studying inherited platelet disorders.
Knock-in
Tagged knock-in of fluorescent reporters enables live tracking of proteins during proplatelet formation and platelet release. Knock-in of lineage markers can also trace alternative platelet differentiation pathways.
Overexpression
Overexpression of genes such as PF4 or LPA16:0-related enzymes can enhance or perturb platelet morphogenesis and downstream neurogenesis. This strategy helps identify gain-of-function effects in platelet biology.
How EDITGENE Supports platelet morphogenesis Research
Researchers studying platelet morphogenesis-related genes often need to determine whether a candidate gene is causally involved in platelet production, organization, or function. EDITGENE provides CRISPR-based cell model services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for platelet morphogenesis research.
Frequently Asked Questions About platelet morphogenesis
What is platelet morphogenesis?
Platelet morphogenesis (GO:0036344) is the generation and organization of platelets, the non-nucleated disk-shaped blood cells formed by extrusion from megakaryocytes that are mainly involved in blood coagulation.
What genes are involved in platelet morphogenesis?
Genes involved include PF4 (CXCL4), LPA16:0-related pathways, megakaryocyte lineage genes, neuronal guidance proteins, and hematopoietic stem cell markers.
Where does platelet morphogenesis occur?
Platelet morphogenesis occurs primarily in the bone marrow, but the lung has been identified as a major site of platelet biogenesis and a reservoir for haematopoietic progenitors.
How are platelets formed from megakaryocytes?
Megakaryocytes extend proplatelets that fragment to release platelets, a process requiring cytoskeletal reorganization and influenced by neuronal guidance proteins.
Can platelets be made from stem cells?
Yes, induced pluripotent stem cells can be differentiated into megakaryocytes and functional platelets, providing a model for studying platelet morphogenesis.
What diseases are linked to platelet morphogenesis?
Defects in platelet morphogenesis can cause thrombocytopenia and platelet function disorders, and platelet-derived factors influence neurogenesis and cognitive aging.
How do platelets affect the brain?
Platelet-derived CXCL4/platelet factor 4 rejuvenates hippocampal neurogenesis and restores cognitive function in aged mice, while LPA16:0 inhibits stress resilience and neurogenesis.
What are alternative platelet differentiation pathways?
Nonhierarchically related hematopoietic stem cells can initiate alternative platelet differentiation pathways, expanding the classical megakaryocyte-centric model.
What methods are used to study platelet morphogenesis?
Methods include iPSC differentiation, live-cell imaging, flow cytometry, RNA sequencing, proteomics, and CRISPR screening.
How can CRISPR help study platelet morphogenesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional testing of candidate genes in megakaryocytes and platelets.
Conclusion
Platelet morphogenesis (GO:0036344) is a dynamic biological process that generates and organizes platelets from megakaryocytes, with critical roles in haemostasis and emerging functions in neurogenesis and tissue repair. The identification of the lung as a platelet biogenesis site and alternative differentiation pathways has broadened our understanding of platelet production. Continued research using CRISPR models and stem cell-derived megakaryocytes will further elucidate the molecular mechanisms and therapeutic potential of platelet morphogenesis.
References
- 1. Lefrançais E et al.. 2017. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors.. Nature 544(7648):105-109 PMID: 28329764
- 2. Leiter O et al.. 2023. Platelet-derived exerkine CXCL4/platelet factor 4 rejuvenates hippocampal neurogenesis and restores cognitive function in aged mice.. Nat Commun 14(1):4375 PMID: 37587147
- 3. Carrelha J et al.. 2024. Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells.. Nat Immunol 25(6):1007-1019 PMID: 38816617
- 4. NyamErdene A et al.. 2026. Platelet concentrate-derived extracellular vesicles promote adult hippocampal neurogenesis.. Biomaterials 328:123838 PMID: 41218272
- 5. Tang L et al.. 2023. Platelet formation and activation are influenced by neuronal guidance proteins.. Front Immunol 14:1206906 PMID: 37398659
- 6. Sugimoto N et al.. 2017. Platelet production from induced pluripotent stem cells.. J Thromb Haemost 15(9):1717-1727 PMID: 28752663
- 7. Larrieu T et al.. 2026. Inhibition of stress resilience and adult hippocampal neurogenesis by platelet-derived LPA16:0 in anxiety.. Nat Commun 17(1) PMID: 41651838
- 8. Smith BW et al.. 2014. Stem cells, megakaryocytes, and platelets.. Curr Opin Hematol 21(5):430-7 PMID: 25023469
